Lupin Q2 cons net profit up 46% at Rs 75.6 cr

19527 Investors following Lupin. Share this News with them.

0

Like this story, share it with millions of investors on M3

Lupin Q2 cons net profit up 46% at Rs 75.6 cr

Lupin has declared its second quarter numbers. Its consolidated net profit has jumped by 46% to Rs 75.6 crore for the quarter ended September 2007 as against Rs 51.8 crore. Net sales increased by 39.6% to Rs 675.6 crore from Rs 483.9 crore.

Post your opinion here

 

0

Tweet

Share on Tumblr

Lupin has declared its second quarter numbers. Its consolidated net profit has jumped by 46% to Rs 75.6 crore for the quarter ended September 2007 as against Rs 51.8 crore. Net sales increased by 39.6% to Rs 675.6 crore from Rs 483.9 crore. 

Consolidated operating profit stood at Rs 131.4 crore versus Rs 71.5 crore. Operating profit margin improved to 19.4% from 14%.

Standalone net profit surged by 102% to Rs 118.08 crore from Rs 58.3 crore and net sales by 45% to Rs 714 crore from Rs 491.07 crore.

Standalone operating profit rose to Rs 141.2 crore from Rs 78.7 crore and operating profit margin improved to 19.7% from 16%.

Highlights

• Lupin standalone numbers are bigger than consolidated number, because of inventory buildup for preparation of new launches to US in the winter season.
• Driven by US market sales, finished dosage export revenue up 99%
• API revenues up 20%
• Domestic finished dosage revenues up 22% - EBITDA up 41% at Rs 1,314 million
• Cefdinir market share at 14%, Price erosion not seen at the moment